114 related articles for article (PubMed ID: 32558229)
1. Affibody-Conjugated RALA Polymers Delivering Oligomeric 5-Fluorodeoxyuridine for Targeted Therapy of HER2 Overexpressing Gastric Cancer.
Zhang F; Yin J; Zhang C; Han M; Wang X; Fu S; Du J; Zhang H; Li W
Macromol Biosci; 2020 Jul; 20(7):e2000083. PubMed ID: 32558229
[TBL] [Abstract][Full Text] [Related]
2. Enhancing Antitumor Efficacy of Nucleoside Analog 5-Fluorodeoxyuridine on HER2-Overexpressing Breast Cancer by Affibody-Engineered DNA Nanoparticle.
Zhang C; Han M; Zhang F; Yang X; Du J; Zhang H; Li W; Chen S
Int J Nanomedicine; 2020; 15():885-900. PubMed ID: 32103944
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of 5-fluorodeoxyuridine and doxorubicin via gold nanoparticle equipped with affibody-DNA hybrid strands for targeted synergistic chemotherapy of HER2 overexpressing breast cancer.
Zhang C; Zhang F; Han M; Wang X; Du J; Zhang H; Li W
Sci Rep; 2020 Dec; 10(1):22015. PubMed ID: 33328545
[TBL] [Abstract][Full Text] [Related]
4. Affibody Modified G-quadruplex DNA Micelles Incorporating Polymeric 5-Fluorodeoxyuridine for Targeted Delivery of Curcumin to Enhance Synergetic Therapy of HER2 Positive Gastric Cancer.
Zhang C; Fu S; Zhang F; Han M; Wang X; Du J; Zhang H; Li W
Nanomaterials (Basel); 2022 Feb; 12(4):. PubMed ID: 35215023
[TBL] [Abstract][Full Text] [Related]
5. Amphiphilic Cationic Peptide-Coated PHA Nanosphere as an Efficient Vector for Multiple-Drug Delivery.
Zhang F; Zhang C; Fu S; Liu H; Han M; Fan X; Zhang H; Li W
Nanomaterials (Basel); 2022 Aug; 12(17):. PubMed ID: 36080060
[TBL] [Abstract][Full Text] [Related]
6. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion.
Focan C; Levi F; Kreutz F; Focan-Henrard D; Lobelle JP; Adam R; Dallemagne B; Jehaes C; Markiewicz S; Weerts J; Bismuth H; Jasmin C; Misset JL
Anticancer Drugs; 1999 Apr; 10(4):385-92. PubMed ID: 10378673
[TBL] [Abstract][Full Text] [Related]
7. Development of a ZHER3-Affibody-Targeted Nano-Vector for Gene Delivery to HER3-Overexpressed Breast Cancer Cells.
Nazari M; Zamani Koukhaloo S; Mousavi S; Minai-Tehrani A; Emamzadeh R; Cheraghi R
Macromol Biosci; 2019 Nov; 19(11):e1900159. PubMed ID: 31531954
[TBL] [Abstract][Full Text] [Related]
8. PLGA Nanoparticles Decorated with Anti-HER2 Affibody for Targeted Delivery and Photoinduced Cell Death.
Shipunova VO; Sogomonyan AS; Zelepukin IV; Nikitin MP; Deyev SM
Molecules; 2021 Jun; 26(13):. PubMed ID: 34203547
[TBL] [Abstract][Full Text] [Related]
9. HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents.
Puri A; Kramer-Marek G; Campbell-Massa R; Yavlovich A; Tele SC; Lee SB; Clogston JD; Patri AK; Blumenthal R; Capala J
J Liposome Res; 2008; 18(4):293-307. PubMed ID: 18937120
[TBL] [Abstract][Full Text] [Related]
10. Effect of dipyridamole on fluorodeoxyuridine cytotoxicity in vitro and in cancer patients.
Buzaid AC; Alberts DS; Einspahr J; Mosley K; Peng YM; Tutsch K; Spears CP; Garewal HS
Cancer Chemother Pharmacol; 1989; 25(2):124-30. PubMed ID: 2532072
[TBL] [Abstract][Full Text] [Related]
11. Efficient intracellular delivery of 5-fluorodeoxyuridine into colon cancer cells by targeted immunoliposomes.
Koning GA; Kamps JA; Scherphof GL
Cancer Detect Prev; 2002; 26(4):299-307. PubMed ID: 12430634
[TBL] [Abstract][Full Text] [Related]
12. Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells.
Rodríguez-Serrano F; Mut-Salud N; Cruz-Bustos T; Gomez-Samblas M; Carrasco E; Garrido JM; López-Jaramillo FJ; Santoyo-Gonzalez F; Osuna A
Int J Nanomedicine; 2016; 11():4777-4785. PubMed ID: 27698563
[TBL] [Abstract][Full Text] [Related]
13. Three methods for 18F labeling of the HER2-binding affibody molecule Z(HER2:2891) including preclinical assessment.
Glaser M; Iveson P; Hoppmann S; Indrevoll B; Wilson A; Arukwe J; Danikas A; Bhalla R; Hiscock D
J Nucl Med; 2013 Nov; 54(11):1981-8. PubMed ID: 24115530
[TBL] [Abstract][Full Text] [Related]
14. Site-specific radiometal labeling and improved biodistribution using ABY-027, a novel HER2-targeting affibody molecule-albumin-binding domain fusion protein.
Orlova A; Jonsson A; Rosik D; Lundqvist H; Lindborg M; Abrahmsen L; Ekblad C; Frejd FY; Tolmachev V
J Nucl Med; 2013 Jun; 54(6):961-8. PubMed ID: 23528382
[TBL] [Abstract][Full Text] [Related]
15. Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine.
Hu N; Yin JF; Ji Z; Hong Y; Wu P; Bian B; Song Z; Li R; Liu Q; Wu F
Cell Physiol Biochem; 2017; 44(6):2158-2173. PubMed ID: 29241186
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intraperitoneal continuous infusion of floxuridine and bolus administration in a peritoneal gastric cancer xenograft model.
Inoue K; Onishi H; Kato Y; Michiura T; Nakai K; Sato M; Yamamichi K; Machida Y; Nakane Y
Cancer Chemother Pharmacol; 2004 May; 53(5):415-22. PubMed ID: 15132129
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent effects of floxuridine (FUdR) on senescent pathology and mortality in the nematode Caenorhabditis elegans.
Wang H; Zhao Y; Zhang Z
Biochem Biophys Res Commun; 2019 Feb; 509(3):694-699. PubMed ID: 30611569
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of human epidermal growth factor receptor 2/neu oncogene by corosolic acid induces cell cycle arrest and apoptosis in NCI-N87 human gastric cancer cells.
Lee MS; Cha EY; Thuong PT; Kim JY; Ahn MS; Sul JY
Biol Pharm Bull; 2010; 33(6):931-7. PubMed ID: 20522955
[TBL] [Abstract][Full Text] [Related]
19. Potent inhibition of human gastric cancer by HER2-directed induction of apoptosis with anti-HER2 antibody and caspase-3 fusion protein.
Zhang DX; Zhao PT; Xia L; Liu LL; Liang J; Zhai HH; Zhang HB; Guo XG; Wu KC; Xu YM; Jia LT; Yang AG; Chen SY; Fan DM
Gut; 2010 Mar; 59(3):292-9. PubMed ID: 19951902
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.
Kemeny N; Seiter K; Niedzwiecki D; Chapman D; Sigurdson E; Cohen A; Botet J; Oderman P; Murray P
Cancer; 1992 Jan; 69(2):327-34. PubMed ID: 1303612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
